Table 1. Patient characteristics.
Variables | Total (n=48) | Low EF group (n=15) | Normal EF group (n=33) |
---|---|---|---|
Age, years | 84.7 [6.8] | 83.2 [7.2] | 85.4 [6.5] |
Female | 23 (47.9) | 6 (40.0) | 17 (51.5) |
Body mass index, kg/m2 | 28.7 [6.8] | 29.7 [8.1] | 28.3 [6.1] |
Approach | |||
Trans-femoral | 39 (81.3) | 11 (73.3) | 28 (84.8) |
Trans-apical | 9 (18.8) | 4 (26.7) | 5 (15.2) |
Intra-op complications | 6 (12.5) | 1 (6.7) | 5 (15.2) |
Atrial fibrillation | 21 (43.8) | 5 (33.3) | 16 (48.5) |
Asthma | 2 (4.2) | 0 (0.0) | 2 (6.1) |
CABG | 14 (29.2) | 5 (33.3) | 9 (27.3) |
CAD | 43 (89.6) | 14 (93.3) | 29 (87.9) |
CKD | 29 (60.4) | 12 (80.0) | 17 (51.5) |
COPD | 17 (35.4) | 6 (40.0) | 11 (33.3) |
Carotid artery disease | 9 (18.8) | 3 (20.0) | 6 (18.2) |
Dyslipidemia | 27 (56.3) | 9 (60.0) | 18 (54.5) |
Diabetes | 20 (41.7) | 7 (46.7) | 13 (39.4) |
NYHA | |||
1–2 | 15 (31.2) | 2 (13.3) | 13 (39.4) |
3–4 | 33 (68.8) | 13 (86.7) | 20 (60.6) |
AR | |||
Non-mild | 21 (43.8) | 8 (53.3) | 13 (39.4) |
Moderate-severe | 27 (56.2) | 7 (46.7) | 20 (60.6) |
MR | |||
Non-mild | 17 (35.4) | 5 (33.3) | 12 (36.4) |
Moderate-severe | 31 (64.6) | 10 (66.7) | 21 (63.6) |
LVH | 43 (89.6) | 13 (86.7) | 30 (90.9) |
Data are presented as mean [standard deviation] or n (%). CABG, coronary artery bypass grafting; CAD, coronary artery disease; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; EF, ejection fraction; NYHA, New York Heart Association; AR, aortic valve regurgitation; MR, mitral valve regurgitation; LVH, left ventricular hypertrophy.